MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
Condition(s) studied
Investigational drug(s) / intervention(s)
MRI 3T: Magnetic Resonance Imaging 3 Tesla
MRI 1,5T: Magnetic Resonance Imaging 1,5 Tesla
MRI 7T: Magnetic Resonance Imaging 7 Tesla
Study summary
Multiple sclerosis (MS) is the first non-traumatic cause of disability in young people, responsible for physical but also cognitive deficits. MS is an inflammatory demyelinating and degenerative disease of the central nervous system. Recently, MRI technics have demonstrated their sensibility to the different processes involved in MS. Particularly, MRI has evidenced that the pathological process of MS is not restricted to the macroscopic lesions of the white matter but also involves the normal appearing white and grey matter. In the normal appearing brain tissue, demyelination, neuronal suffering and neuronal loss have been evidenced. Moreover, MRI has demonstrated the existence of brain functional reorganization processes that may limit the clinical expression of pathological injuries. Despite these important findings, the pathological underpinnings of irreversible disability are largely unknown. The present project aims to depict the main determinants of physical but also cognitive disability in patients with MS. To do this, a longitudinal study including 70 patients with MS using different MRI markers known to be sensitive to the different pathological aspects of MS will be performed. The relationships between these markers and the progression of disability will be assessed. Identification of the main pathological underpinnings of irreversible disability of MS will provide the most relevant therapeutic targets.
Eligibility
Primary outcome measure(s)
- Measurement of the Expanded Disability Status Scale (EDSS) value (score from 0 to 20) constituing the actual international reference scale to measure the level of disability caused by parkinson disease — 5 years
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Assistance Publique - Hôpitaux de Marseille | Marseille | France |
More Assistance Publique Hopitaux De Marseille trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03356366 on ClinicalTrials.gov ↗ ← All trials in France